Breaking News, Collaborations & Alliances

Elsevier, Novartis Collaborate on Risk Assessment Prediction Tool

To develop a safety margin risk assessment prediction tool, largely using PharmaPendium data.

By: Contract Pharma

Contract Pharma Staff

Elsevier, a global information analytics business specializing in science and health, is collaborating with the pharmaceutical company Novartis to develop a safety margin risk assessment prediction tool, largely using PharmaPendium data.   PharmaPendium provides users with fully searchable drug approval documents and extracted data to inform critical drug development decisions.   The FDA estimates more than 106,000 people die every year due to adverse drug reactions (ADRs). Unanticipated dru...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters